IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — DD

June 24, 2026View Source ↗

On June 23, 2026, DuPont de Nemours, Inc. filed a Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation. This amendment effected a 1-for-3 reverse stock split of the company's common stock and a corresponding reduction in the number of authorized shares. The split became effective at 12:01 a.m. Eastern Time on June 24, 2026. The company's common stock continues to trade on the New York Stock Exchange under the ticker symbol "DD" with a new CUSIP number of 26614N 201. DuPont is a specialty chemicals company that provides science-based solutions for various industrial and consumer markets.

May 26, 2026View Source ↗

DuPont de Nemours, Inc. stockholders approved an amendment to the company's certificate of incorporation to implement a reverse stock split. The Board of Directors has specifically approved a 1-for-3 ratio, which is expected to become effective on June 24, 2026.

May 5, 2026View Source ↗

DuPont de Nemours, Inc. announced its financial results for the first quarter of 2026 on May 5, 2026. The company issued a press release to communicate these results, though no specific financial figures were included in the text of this filing.

April 15, 2026View Source ↗

Luke Kissam resigned from DuPont de Nemours, Inc.'s Board of Directors effective April 14, 2026, to assume the role of Chief Executive Officer at Corteva, Inc. Following his departure, the Company's Board of Directors will decrease in size from eleven to ten members.

March 18, 2026View Source ↗

DuPont de Nemours, Inc. plans to seek stockholder approval for a reverse stock split of its common stock at a ratio of no less than 1-for-2 and no more than 1-for-4. The Board of Directors will determine the exact ratio at a later date, and the proposal will be presented for a vote at the company's upcoming Annual Meeting of Stockholders.

March 16, 2026View Source ↗

DuPont de Nemours, Inc. expects to close the sale of its aramids business, which includes the Kevlar and Nomex brands, to Arclin on April 1, 2026. All regulatory conditions required to complete the transaction were satisfied as of March 10, 2026.